Website & contact details
- Group website
- The site of this company’s group or brand.
Enterprise Therapeutics Holdings Limited
- Incorporated
- 9 September 2020 (6 years)
- Industry
- Other service activities n.e.c. (96090)
- Directors
- Janet Margaret Justine HammondRobbie Woodman
- Accounts type
- Group
- Region
- South East
- Address
- Sussex Innovation Centre Science Park SquareFalmerBN1 9SB
Filing status
- Accounts due
- 31 March 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 22 September 2027
- Last conf. stmt
- 8 September 2026
Officers 10 active
Officer details are public data from the Companies House register.
Hammond, Janet Margaret Justine, Dr
Director · Appointed 20 May 2024
American
Born March 1960 (66)
Woodman, Robbie, Dr
Director · Appointed 5 January 2024
British
Born October 1977 (49)
Director · Appointed 5 October 2020
British
Born July 1967 (59)
Director · Appointed 5 October 2020
American,Swiss
Born March 1968 (58)
Mulder, Geert-Jan, Dr
Director · Appointed 5 October 2020
Dutch
Born July 1966 (60)
Director · Appointed 5 October 2020
British
Born July 1974 (52)
Director · Appointed 5 October 2020
Canadian
Born March 1976 (50)
Director · Appointed 5 October 2020
German
Born March 1975 (51)
Director · Appointed 5 October 2020
Also at C Biologics Holdco Limited (proposed for strike-off), C Biologics Newco Limited (proposed for strike-off) · more companies
British
Born September 1976 (50)
Boyd, Philip James, Dr
Secretary · Appointed 9 September 2020
Officer history (1 former)
20 May 2024
Appointed Hammond, Janet Margaret Justine, Dr as Director
5 January 2024
Appointed Woodman, Robbie, Dr as Director
5 October 2020
5 October 2020
5 October 2020
Appointed Mulder, Geert-Jan, Dr as Director
5 October 2020
5 October 2020
5 October 2020
5 October 2020
5 October 2020
Resigned Boyd, Philip James, Dr as Director
9 September 2020
Appointed Boyd, Philip James, Dr as Secretary
9 September 2020
Appointed Boyd, Philip James, Dr as Director
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Holdings 1
Companies where Enterprise Therapeutics Holdings Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Former controllers (1)
5 October 2020
Ceased Philip James Boyd — Owns 75–100% of shares
Financials
Figures from 2025 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Profit
- (£1,179,029)
- Employees
- 18
Trend
Employees
Balance sheet detail
| 2025 | 2024 | 2021 | |
|---|---|---|---|
| Fixed Assets | £1,919,608 | ||
| Current Assets | £5,061,664 | £6,216,938 | £2,127,018 |
| Cash | £2,122,213 | ||
| Creditors (< 1 year) | £15,275 | ||
| Net Current Assets | £2,111,743 | ||
| Net Assets | £4,031,351 | ||
| Shareholder Funds | £4,031,351 |
Filings 65
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 28 September 2026 | Statement of capital following an allotment of shares | |||
| 18 September 2026 | Confirmation statement with updates | 8 September 2026 | ||
| 7 September 2026 | Statement of capital following an allotment of shares | |||
| 14 August 2026 | Previous accounting period shortened | |||
| 18 April 2026 | Group of companies' accounts | 31 December 2025 |
Some other companies at this address
Other companies in this industry
London
London
Warwick
London
Cambridge
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →